Selectis Health, Inc.
GBCS
$3.10
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 0.00 | 0.00 | 161.00K | 321.30K |
| Total Other Revenue | 41.44M | 42.17M | 41.34M | 40.33M | 39.17M |
| Total Revenue | 41.44M | 42.17M | 41.34M | 40.49M | 39.49M |
| Cost of Revenue | 31.76M | 32.62M | 31.68M | 30.94M | 30.36M |
| Gross Profit | 9.68M | 9.54M | 9.66M | 9.55M | 9.13M |
| SG&A Expenses | 9.77M | 9.36M | 10.34M | 10.49M | 10.29M |
| Depreciation & Amortization | 1.47M | 1.45M | 1.46M | 1.51M | 1.57M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 43.01M | 43.43M | 43.48M | 42.94M | 42.22M |
| Operating Income | -1.56M | -1.27M | -2.14M | -2.45M | -2.73M |
| Income Before Tax | -1.01M | -788.10K | -3.15M | -2.05M | -2.42M |
| Income Tax Expenses | 800.00 | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.02 | -0.79 | -3.15 | -2.05 | -2.42 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.02M | -788.10K | -3.15M | -2.05M | -2.42M |
| EBIT | -1.56M | -1.27M | -2.14M | -2.45M | -2.73M |
| EBITDA | -90.20K | 187.00K | -678.30K | -945.20K | -1.16M |
| EPS Basic | -0.34 | -0.27 | -1.04 | -0.68 | -0.80 |
| Normalized Basic EPS | -0.39 | -0.39 | -0.73 | -0.87 | -0.95 |
| EPS Diluted | -0.35 | -0.28 | -1.05 | -0.69 | -0.81 |
| Normalized Diluted EPS | -0.39 | -0.39 | -0.73 | -0.87 | -0.95 |
| Average Basic Shares Outstanding | 12.27M | 12.27M | 12.27M | 12.27M | 12.27M |
| Average Diluted Shares Outstanding | 12.27M | 12.27M | 12.27M | 12.27M | 12.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.10% | -- | -- | -- | -- |